VAB and MRI Following Percutaneous Ultra-Sound Guided Cryoablation for Primary Early-Stage Breast Cancer: A Pilot Study in Japan

Kawamoto, H., Tsugawa, K., Takishita, M., Tazo, M., Nakano, M.H., Tsuruga, T., Oi, R., Kuroda, T., Yoshie, R., Shimo, A., Iwatani, T., Shimo, A., Kojima, Y., Motoyoshi, A., Haku, E., Yabuki, Y., Suto, A., Kanemaki, Y., Mimura, H., Maeda, I. and Fukuda, M. (2021) VAB and MRI Following Percutaneous Ultra-Sound Guided Cryoablation for Primary Early-Stage Breast Cancer: A Pilot Study in Japan. Journal of Cancer Therapy, 12, 563-576. https://doi.org/10.4236/jct.2021.1210047

Summary: 8 female patients were enrolled, between the ages of 52- 72 years old (mean age 61.9) who were diagnosed with invasive ductal carcinoma (IDC) tumors and treated with percutaneous ultrasound-guided cryoablation. All patients received radiation and endocrine therapies. No residual or recurrent malignancies were detected. The study authors concluded that “percutaneous cryoablation of early-stage low-risk breast cancer tumors smaller than 15mm potentially presents a potential substitute for lumpectomy.”  

***Full article may require purchase***